Widespread distribution of nirsevimab to infants with respiratory syncytial virus infection raised concerns about potential ...

It’s time for the provincial government to stop dragging its heels on paying for a pair of injections that can protect the ...

Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's molecular clamp technology against life-threatening respiratory viruses.

the Department of Public Health and Human Services (DPHHS) is encouraging Montanans to take precautions to help protect against COVID-19, influenza, pneumococcal pneumonia and respiratory syncytial ...